Jack Ball is of Cytek Biosciences, Inc.. Currently has a direct ownership of 26,999 shares of CTKB, which is worth approximately $137,964. The most recent transaction as insider was on Nov 29, 2022, when has been sold 23,999 shares (Common Stock) at a price of $0.66 per share, resulting in proceeds of $15,839. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 27K
0% 3M change
0% 12M change
Total Value Held $137,964

Jack Ball Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 29 2022
BUY
Exercise of conversion of derivative security
$15,839 $0.66 p/Share
23,999 Added 47.06%
26,999 Common Stock
Nov 14 2022
SELL
Open market or private sale
$235,040 $14.69 p/Share
16,000 Reduced 84.21%
3,000 Common Stock
Nov 14 2022
BUY
Exercise of conversion of derivative security
$6,400 $0.4 p/Share
16,000 Added 45.71%
19,000 Common Stock
Jul 22 2021
BUY
Open market or private purchase
$51,000 $17.0 p/Share
3,000 Added 50.0%
3,000 Common Stock
JB

Jack Ball

Fremont, CA

Track Institutional and Insider Activities on CTKB

Follow Cytek Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CTKB shares.

Notify only if

Insider Trading

Get notified when an Cytek Biosciences, Inc. insider buys or sells CTKB shares.

Notify only if

News

Receive news related to Cytek Biosciences, Inc.

Track Activities on CTKB